Intellectual Property

  • March 30, 2026

    X Corp. Invokes Cox Ruling To Challenge Music Copyright Suit

    X Corp. has argued that a ruling from the U.S. Supreme Court last week that an internet service provider couldn't be held liable for its customers pirating music should allow it to escape copyright infringement claims in Tennessee federal court from a group of music publishers.

  • March 30, 2026

    X Gets Backup In Fed. Circ. Fight Against $175M Patent Loss

    Patent quality advocacy group Askeladden LLC has backed X Corp.'s Federal Circuit challenge to a loss of more than $175 million that it saw in a patent infringement suit, saying the patented claims at issue should have been found invalid to begin with.

  • March 30, 2026

    Justices Told Fed. Circ. Wrongly Axed Car ID Patent Claims

    A vehicle identification system patent owner wants the U.S. Supreme Court to review the Federal Circuit's reversal of the Patent Trial and Appeal Board's decision allowing the company to amend claims in two patents challenged by rideshare giant Lyft.

  • March 30, 2026

    Patent Monetization Co. Looks To Sink $32M Arbitration Award

    A patent monetization firm has sued a litigation funder and law firm Susman Godfrey LLP in Texas federal court, seeking to vacate an arbitration award that it says was riddled with errors.

  • March 30, 2026

    Former Intel Engineer Fights Trade Secret Suit

    A former Intel engineer has asked a Washington federal court to dismiss a lawsuit alleging he stole nearly 18,000 files before his employment was terminated in July, saying he wasn't properly notified of the case and responded promptly when he found out about it.

  • March 30, 2026

    Sanofi Claims IP Life Extension Needed For Double Patenting

    The Patent Trial and Appeal Board rightly found a Sanofi patent application shouldn't be rejected for obviousness-type double patenting, as it doesn't improperly extend patent life, the French drugmaker and its allies have told U.S. Patent and Trademark Office Director John Squires.

  • March 30, 2026

    Catching Up With Delaware's Chancery Court

    The Delaware Chancery Court's docket this past week featured disputes involving globally recognized companies, high-dollar contract fights, revived claims from the state's high court and the resolution of a closely watched de-SPAC case.

  • March 30, 2026

    Fastener Co. Can't Slip $17K TM Infringement Judgment

    A Pennsylvania federal judge has upheld a $17,000 trademark infringement judgment against industrial fastener company Peninsula Components after it was found liable for using its competitor Penn Engineering & Manufacturing Corp's "PEM" name in Google Ads, ruling that the defendant presented no compelling reason to erase the verdict.

  • March 30, 2026

    Tilray Accused Of Dodging $11M In Bob Marley Royalties

    Multistate cannabis giant Tilray owes more than $11 million in royalty payments for using Bob Marley's brand in connection with marijuana products, according to a new lawsuit filed in Delaware Chancery Court.

  • March 30, 2026

    Hunter S. Thompson Whiskey Brand Sued Over IG Photos

    The owner of the copyright to pictures taken by Hunter S. Thompson's personal photographer claimed in Colorado federal court Monday that the whiskey brand owned by Thompson's estate violated copyright law by posting some of the photos on their social media.

  • March 30, 2026

    TriZetto's $70M Trade Secret Verdict Upheld, Total Award Cut

    A New York federal judge has upheld a $70 million compensatory damages verdict for the TriZetto Group in a long-running trade secret fight against Syntel Inc., while also cutting punitive damages to about $140 million and awarding TriZetto more than $12 million in attorney fees.

  • March 30, 2026

    Del. Judge Upholds $34M Verdict In Glaucoma Patent Feud

    A Delaware federal judge has affirmed a $34 million verdict against Alcon and related entities for infringing patents covering medical devices to treat glaucoma, disagreeing that Sight Sciences Inc. had failed to show the accused product meets the limitations of the patent claims.

  • March 30, 2026

    Nationwide Need Not Cover Marker Makers' Trade Secret Fight

    Four Nationwide units have no duty to defend a marker manufacturer in an underlying suit by a competitor alleging it colluded with former employees to use trade secrets and other proprietary information, a Pennsylvania federal judge ruled.

  • March 30, 2026

    J&J Unit Wants Forensic Exam Of Ex-Director's Devices

    A Johnson & Johnson subsidiary urged a New Jersey federal court to order a former associate director to submit to a court-supervised forensic inspection of any device or account in which she could have stored confidential information it claims she downloaded in order to start her own competing company.

  • March 30, 2026

    Retailers Not Covered In Trademark Infringement Dispute

    An insurer has no duty to defend a home goods retailer accused of using another company's trademark in its online advertising and marketing, an Illinois federal court ruled, finding that the underlying suit does not allege a covered personal and advertising injury.

  • March 30, 2026

    High Court Turns Away CRISPR Patent Validity Dispute

    The U.S. Supreme Court on Monday rejected Agilent Technologies' bid to revive patents on the gene-editing tool CRISPR, which centers on the burden of proof in establishing prior art.

  • March 30, 2026

    Justices Reject TM Appeal Tied To 'Use In Commerce'

    The U.S. Supreme Court on Monday declined to take up an appeal challenging a Ninth Circuit ruling that upheld a multimillion-dollar default judgment based largely on statements defendants made in trademark applications.

  • March 27, 2026

    Injunction Constraints Impede Utility Patent Counterfeit Cases

    A Texas federal judge ruled this month that the strongest tool to stop counterfeiters in so-called Schedule A cases doesn't apply to utility patents, which attorneys say cements a long-standing practice of retailers relying on trademarks and design patents.

  • March 27, 2026

    Inventors Back Dolby's Interested-Party High Court Fight

    A group representing inventors and entrepreneurs is supporting Dolby's bid to have the U.S. Supreme Court review a Federal Circuit dismissal of the company's appeal of a Patent Trial and Appeal Board proceeding it won, citing the importance of knowing which parties are behind a patent challenge.

  • March 27, 2026

    Hemp Co. Seeks To Cancel Popular 'Lost Mary' Vape TM

    A North Carolina hemp provider is looking to cancel the popular "Lost Mary" vape trademark, held by the Chinese company that also sells Elf Bars, telling a California federal court that it was always invalid because it's illegal to sell flavored vapes.

  • March 27, 2026

    NCAA's Anti-Sports Betting Stance Becomes An IP Issue

    The National Collegiate Athletic Association has kicked off a legal battle with a trademark infringement lawsuit against DraftKings for using terms like "March Madness" to describe the basketball competition, bringing the issue of sports betting to court and signaling a more active role in intellectual property enforcement.

  • March 27, 2026

    Eli Lilly Keeps Most Of Weight Loss Drug Copy Suit Alive

    A California federal judge has refused to throw out a lawsuit accusing a pair of telehealth companies of making copies of Eli Lilly's obesity and type 2 diabetes drugs but agreed to trim the case.

  • March 27, 2026

    ITC Will Review Solar Cell Imports For Infringement

    The U.S. International Trade Commission is launching an investigation into claims by an Arizona-based solar company accusing nearly 50 companies of importing solar cells into the U.S. that infringe one of its patents.

  • March 27, 2026

    NC Biz Court Bulletin: Judge Exits, Duke Ducks Climate Suit

    The North Carolina Business Court saw an unexpected shakeup with one judge's retirement, rendered a pivotal decision in a first-of-its-kind climate change case against Duke Energy and oversaw a trial between the feuding owners of a commercial bed skirt company.

  • March 27, 2026

    Skull Shaver Can't Stop NJ Judge From Moving IP Suit To NC

    A New Jersey federal judge has adopted the recommendation of a magistrate judge who said Skull Shaver's patent infringement case against The Cut Buddy over electronic razor technology could move to North Carolina federal court.

Expert Analysis

  • Have Iconic Twitter Trademarks Been Abandoned?

    Author Photo

    A set of lawsuits concerning the status of X Corp.'s "Twitter" and "tweet" trademarks, which will potentially be considered abandoned in July, will provide instructive insights into how trademark owners can defend against abandonment claims, say attorneys at Bradley Arant.

  • Google's Scraping Suit Asks How Far DMCA Protections Go

    Author Photo

    A California federal court's decision in Google v. SerpApi will spotlight a long-developing judicial split over how to apply the Digital Millennium Copyright Act’s ban on circumventing a copyright holder’s access controls, an increasingly important point in litigation over web scraping and artificial intelligence training, say attorneys at Jenner & Block.

  • Trial Advocacy Lessons From 3 Oscar-Nominated Films

    Author Photo

    Several films up for best picture at this weekend’s Academy Awards provide useful tips for trial lawyers, from the power of a dramatic opening to the importance of pivoting when the unexpected happens, say attorneys at Robins Kaplan.

  • Series

    Podcasting Makes Me A Better Lawyer

    Author Photo

    Podcasting has changed how I ask questions and connect with people, sharpening my ability to listen without interrupting or prejudging, and bringing me closer to what law is meant to be: a human profession grounded in understanding, judgment and trust, says Donna DiMaggio Berger at Becker.

  • Patent Eligibility Bulletin: Steps To Consider As USPTO Shifts

    Author Photo

    Recent memoranda from the U.S. Patent and Trademark Office, along with some of the first patents issued under Director John Squires, indicate a recalibration of the subject matter eligibility landscape, signaling a renewed emphasis on concrete technological improvements and a potentially pro-AI stance, say attorneys at Banner Witcoff.

  • Opinion

    Fed. Circ. Must Bury Design Patent Doctrinal Zombies

    Author Photo

    After recently finding noninfringement in Range of Motion Products v. Armaid, the Federal Circuit must rehear the case to confront two troublesome doctrines of design patent law claim construction — feature filtration and claim verbalization — that have lingered for decades and intensified in recent years, say attorneys at McAndrews Held.

  • Why La. Ruling May Open NIL Deals For Int'l Student-Athletes

    Author Photo

    A Louisiana federal court's decision to deny a motion to dismiss in Poa v. Jaddou, a case over whether international student-athletes may engage in name, image and likeness deals, signals that courts are willing to challenge rigid interpretations of immigration law in light of modern collegiate athletics, say attorneys at Shook Hardy.

  • Weighing Confusion Claims In Shoes-NFL Steakhouse TM Suit

    Author Photo

    A recent New York federal infringement complaint by 1587 Sneakers against Patrick Mahomes and Travis Kelce's Kansas City steakhouse 1587 Prime confronts the thorny question of how much operating in different industries should factor into likelihood-of-confusion analysis and why consumer perception can matter most in trademark fights, says Nate Garhart at Spencer West.

  • Unique Issues Facing Brand-Compounder Patent Litigation

    Author Photo

    Recent litigation and potential enforcement action against Hims & Hers Health raise questions about how compounders and branded pharmaceuticals companies would be positioned in patent litigation as compared to generics companies, which would require strategies different from those that would be used in traditional Hatch-Waxman Act litigation, say attorneys at Morgan Lewis.

  • Series

    Volunteering With Scouts Makes Me A Better Lawyer

    Author Photo

    Serving as an assistant scoutmaster for my son’s troop reaffirmed several skills and principles crucial to lawyering — from the importance of disconnecting to the value of morality, says Michael Warren at McManis Faulkner.

  • AI Communications May Be Discoverable In Patent Litigation

    Author Photo

    A New York federal court's recent determination that a defendant's correspondence with an artificial intelligence tool was not protected by attorney-client privilege may have significant ramifications for patent matters, highlighting the risk of AI use in patent prosecution and litigation tasks, say attorneys at Seed IP.

  • Series

    Law School's Missed Lessons: In Court, It's About Storytelling

    Author Photo

    Law school provides doctrine, cases and hypotheticals, but when lawyers step into the courtroom, they must learn the importance of clarity, credibility, memorability and preparation — in other words, how to tell simple, effective stories, say Nicholas Steverson and Danielle Trujillo at Wheeler Trigg, and Lisa DeCaro at Courtroom Performance.

  • High Court's 'Skinny Label' Case May Tackle Wider Questions

    Author Photo

    The U.S. Supreme Court's upcoming decision in Hikma v. Amarin will have important ramifications for broader debates over what defines a generic version of a drug, and the pending case is already altering patent practice, say attorneys at Taft.

  • Aligning Microsoft Tools With NYC Bar AI Recording Guidance

    Author Photo

    The New York City Bar Association’s recently issued formal opinion, providing ethical guidance on artificial intelligence-assisted recording, transcription and summarization, raises immediate questions about data governance and e-discovery for companies that use Microsoft 365 and Copilot, say Staci Kaliner, Martin Tully and John Collins at Redgrave.

  • FDA's Biosimilarity Guidance Holds Uncertain Implications

    Author Photo

    The U.S. Food and Drug Administration's new draft guidance aimed at simplifying the biosimilarity demonstration process may not be enough to overcome the barriers that have historically constrained biosimilar competition, and could affect biosimilar access in unexpected ways, say analysts at Analysis Group.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Intellectual Property archive.